Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Net Income ContractionContracting
Percentile Rank14
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-575.00M
↓ 35% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-424.72M
Historical baseline
PeriodValueYoY Change
2025$-575.00M-1.0%
2024$-569.18M+6.2%
2023$-606.64M+14.2%
2022$-707.42M-55.8%
2021$-454.02M-143.4%
2020$-186.57M+53.7%
2019$-402.73M-103.8%
2018$-197.61M+34.6%
2017$-302.14M-22.9%
2016$-245.87M-